Indicators

Markets:

News

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9

...

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

January 13, 2025

Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?

January 13, 2025

Enduring Truths for Investors Both New and Seasoned

January 11, 2025

Peering Into Biogen's Recent Short Interest

January 09, 2025

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected

January 07, 2025

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

January 04, 2025

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

January 03, 2025

17 Analysts Assess Biogen: What You Need To Know

January 02, 2025

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

December 20, 2024

Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory?

December 11, 2024

Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown

December 09, 2024

This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

December 09, 2024

Assessing Biogen: Insights From 19 Financial Analysts

December 09, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

December 02, 2024

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over

November 26, 2024

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside

November 20, 2024

Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026

November 18, 2024

This Biogen Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

November 18, 2024

Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday

November 15, 2024

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

November 14, 2024

Evaluating Biogen: Insights From 17 Financial Analysts

November 04, 2024

Biogen Analysts Slash Their Forecasts After Q3 Results

October 31, 2024

This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

October 31, 2024

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

October 30, 2024

Biogen (BIIB) Q3 2024 Earnings Call Transcript

October 30, 2024

Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook

October 30, 2024

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock

October 23, 2024

Looking Into Biogen's Recent Short Interest

October 22, 2024

After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce

October 17, 2024

Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock

October 16, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.